Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Knudsen, DK
Andreas Groth Knudsen, Brande DK
| Patent application number | Description | Published |
|---|---|---|
| 20100127495 | ESTIMATING AN ACHIEVABLE POWER PRODUCTION OF A WIND TURBINE BY MEANS OF A NEURAL NETWORK - A method for estimating an achievable power production of a wind turbine, which is operated with a reduced power set point is provided. The method includes determining the values of at least two parameters, inputting the values of the at least two parameters into a neural network, and outputting an output value from the neural network. The at least two parameters are indicative of an operating condition of the wind turbine. Thereby, the output value is an estimate of the achievable power production of the wind turbine. A control system which is adapted to carry out the described power estimation method is also provided. Furthermore, a wind turbine which uses the control system adapted to carry out the described power estimation method is provided. | 05-27-2010 |
Breian Knudsen, Albertslund DK
| Patent application number | Description | Published |
|---|---|---|
| 20100029721 | Pharmaceutical Formulation Comprising Metformin and Repaglinide - The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation. | 02-04-2010 |
| 20110294852 | Pharmaceutical Formulation Comprising Metformin and Repaglinide - The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation. | 12-01-2011 |
Carsten Boye Knudsen, Greve DK
| Patent application number | Description | Published |
|---|---|---|
| 20080287478 | Nociceptin Analogues and Uses Thereof - The present invention relates to nociceptin analogues and uses thereof to modulate biological functions. In one aspect, the invention provides modified triazo-spiro compounds that include at least one specialized chemical group that is bound to the compounds. The invention has a wide range of applications including providing a new class of therapeutically useful aquatics. | 11-20-2008 |
| 20090208565 | STABILIZED EXENDIN-4 COMPOUNDS - The present invention discloses compositions comprising a stabilized Exendin-4 (1-39) and related compounds. The invention describes stabilized Exendin-4 agonists that include at least one modified amino acid residue particularly at positions Gln13, Met14, Trp25, or Asn28 of the Exendin-4 (1-39) molecule. Disclosed are preferred modifications of deaminated, hydrolyzed, oxidized, or isomerized reaction products of the specified amino acid residues corresponding to the same positions in the Exendin-4 (1-39) molecule. The invention also relates to methods of making and using the stabilized Exendin compounds, such as for the treatment of diabetes. | 08-20-2009 |
| 20100048462 | TRUNCATED PTH PEPTIDES WITH A CYCLIC CONFORMATION - The present invention provides PTH peptides which are cyclised substitution analogues of the truncated PTH fragment PTH (1-17) and which preferably retain the desired or similar biological activity of human PTH (1-34). | 02-25-2010 |
Claus W. Knudsen, Allinge DK
| Patent application number | Description | Published |
|---|---|---|
| 20090010407 | COMMUNICATIONS SYSTEMS AND METHODS USING WIRELINE ADAPTERS - Systems and techniques for communication over telephony wireline. A command interface and control device may include a wireline input configured to connect the device to an operative line of a wireline telephony network (such as the PSTN) and to transmit voice signals to and receive voice signals from the wireline telephony network. The device may also include a cellular module configured to transmit signals to and receive signals from a cellular telephony network and a system controller to control communications on the wireline input and the cellular module. One or more wireline adapter modules may be configured to provide control functionality local to a telecommunications device. | 01-08-2009 |
Henrik Knudsen, Silkeborg DK
| Patent application number | Description | Published |
|---|---|---|
| 20100044540 | FLANGE MOUNTING FOR HOLDING A TOWER SECTION - It is described a clamping device for mounting a holder element, in particular a holder element for a wind turbine element, to a support unit. The clamping device includes a clamping element, a fixing element and a mounting element with at least one fixing portion. The mounting element is adapted to be fixed to a support unit. The clamping element is adapted for clamping the holder element to the mounting element. The fixing element is adapted to provide a clamping force to the clamping element for providing a stiction between the holder element and the mounting element. The fixing element is adapted for being flexibly fixed to the at least one flexible fixing portion of the mounting element. | 02-25-2010 |
Ida Molgaard Knudsen, Vaerlose DK
| Patent application number | Description | Published |
|---|---|---|
| 20080254514 | Production of a Polypeptide in a Serum-Free Cell Culture Liquid Containing Plant Protein Hydrolysate - The invention concerns a method for large-scale production of a polypeptide in eukaryote cells contained in a serum-free culture liquid, said method comprising (i) a propagation phase for said cells, where the cells are propagated in a first cell culture liquid, and (ii) a production phase for said cells, where the cells are present in a second cell culture medium liquid, wherein each of the cell culture liquids comprise a plant protein hydrolysate, and wherein the ratio between the concentration of the plant protein hydrolysate (C | 10-16-2008 |
| 20090075331 | Industrial-scale serum-free production of recombinant proteins in mammalian cells - The invention relates to methods for cultivating mammalian cells and for producing recombinant proteins in large-scale cultures of such cells. The proteins are, e.g., Factor VII or Factor VII-related polypeptides. | 03-19-2009 |
| 20090263866 | Industrial-scale Serum-free Production of Recombinant Factor VII in Mammalian Cells - The invention provides a method for industrial-scale production of FVII polypeptides in mammalian cell culture free of animal-derived components. | 10-22-2009 |
Ivan Knudsen, Rodekaersbro DK
| Patent application number | Description | Published |
|---|---|---|
| 20100316503 | PUMP UNIT - The invention relates to a pump assembly with a pump ( | 12-16-2010 |
Jan Vestergaard Knudsen, Aarhus N DK
| Patent application number | Description | Published |
|---|---|---|
| 20100290905 | Wind Turbine Control Method - A method of controlling a wind turbine, where a control signal for a controllable parameter of the wind turbine is determined repeatingly at successive time steps, and a control history including respective control values derived from or included in past control signals is stored. These control values stored in the control history are then used to determine an alert parameter for the controllable parameter, the alert parameter being a function of the variations of the control signals over time. The wind turbine is then controlled according to the most recent control signal only if the alert parameter is below an alert threshold, and otherwise according to a modified control strategy. The control method may be performed on pitch reference signals for controlling the individual and/or collective pitch of the blades. The invention further relates to a control system configured to perform the above control method, and a wind turbine comprising such system. | 11-18-2010 |
Jens Bjerre Knudsen, Farum DK
| Patent application number | Description | Published |
|---|---|---|
| 20100205001 | SYSTEM AND METHOD FOR ASSISTING IN THE HOME TREATMENT OF A MEDICAL CONDITION - An interactive home treatment system and method is disclosed. Patient data is collected via a handheld device and stored in a database. The data may be related to self-treatments, symptoms, or patient behavior. The data are analyzed with an analytic tool and the analysis is used to generate a message that is transmitted to a treating health care professional or to the patient, or both. A set of predetermined rules may be applied to the data. The rules may be modified by the treating health care professional, the patient, or both. The handheld device, the database, and the analytic tool may be web-enabled to facilitate communication from virtually anywhere. | 08-12-2010 |
| 20110077963 | SYSTEM AND METHOD FOR ASSISTING IN THE HOME TREATMENT OF A MEDICAL CONDITION - An interactive home treatment system and method is disclosed. Patient data is collected via a handheld device and stored in a database. The data may be related to self-treatments, symptoms, or patient behavior. The data are analyzed with an analytic tool and the analysis is used to generate a message that is transmitted to a treating health care professional or to the patient, or both. A set of predetermined rules may be applied to the data. The rules may be modified by the treating health care professional, the patient, or both. The handheld device, the database, and the analytic tool may be web-enabled to facilitate communication from virtually anywhere. | 03-31-2011 |
Katrine Knudsen, Arhus DK
| Patent application number | Description | Published |
|---|---|---|
| 20080226679 | Novel surface exposed proteins from chlamydia pneumoniae - The invention relates to the identification of members of a gene family from the human respiratory pathogen | 09-18-2008 |
Kim Grøn Knudsen, Hellerup DK
| Patent application number | Description | Published |
|---|---|---|
| 20100061927 | HYDROTREATMENT PROCESS - A process for the hydrotreating of fuels with co-production of hydrogen during operation of the process, which enables i.e. reduced need of make-up hydrogen in the hydrotreating stage. The hydrocarbon fuel introduced to the hydrotreatment stage is a fuel containing renewable organic material which generates carbon monoxide during operation of the process. The carbon monoxide is then converted to hydrogen in the recycle loop by a water gas shift stage. | 03-11-2010 |
| 20110166396 | HYDROCONVERSION PROCESS AND CATALYST - The invention relates to a process and hydrodeoxygenation catalyst for producing high-quality diesel and naphtha fuels from a feedstock that contains oxygen containing components derived from renewable organic material in which the hydrodeoxygenation catalyst is a supported Mo catalyst and in which the support has a bimodal porous structure. | 07-07-2011 |
Lars Lyhne Knudsen, Aarhus C DK
| Patent application number | Description | Published |
|---|---|---|
| 20100286769 | System For Implanting a Valve Prosthesis - A valve prosthesis ( | 11-11-2010 |
Lars Lyhne Knudsen, Aarhus DK
| Patent application number | Description | Published |
|---|---|---|
| 20100004727 | SYSTEM FOR IMPLANTING A VALVE PROSTHESIS - A valve prosthesis ( | 01-07-2010 |
Leif Knudsen, Grenaa DK
| Patent application number | Description | Published |
|---|---|---|
| 20090017118 | COATED TABLETS, THEIR METHODS OF PREPARATION, AND RELATED USES - The present invention relates to a tablet comprising a tabletted core comprising a triglyceride granulate, and an enteric coating surrounding said tabletted core. The invention particularly relates to a tablet wherein the tabletted core contains esterified omega-3 fatty acids such as eicosapentaenoic acid and/or docosahexaenoic acid. | 01-15-2009 |
Liselotte Bjerre Knudsen, Kalundborg DK
| Patent application number | Description | Published |
|---|---|---|
| 20090286716 | Soluble Pharmaceutical Compositions for Parenteral Administration Comprising a GLP-1 Peptide and an Insulin Peptide of Short Time Action for Treatment of Diabetes and Bulimia - Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide. | 11-19-2009 |
Lotte Bjerre Knudsen, Kalundborg DK
| Patent application number | Description | Published |
|---|---|---|
| 20090149512 | Use of Ghrelin Antagonists to the Treatment of Certain CNS Diseases - Ghrelin antagonists can be used for the treatment of certain CNS disorders. For example, certain oxadiazoles, preferably such being ghrelin antagonists, can be used to treat obesity, e.g., drug-induced obesity. | 06-11-2009 |
Lotte Bjerre Knudsen, Valby DK
| Patent application number | Description | Published |
|---|---|---|
| 20100184690 | Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications - Methods and uses for treatment of diabetic late complications comprising administration of a GLP-1 compound and a modulator of diabetic complications. | 07-22-2010 |
Michael Knudsen, Randers DK
| Patent application number | Description | Published |
|---|---|---|
| 20110264432 | SYSTEM AND METHOD FOR MODELLING A MOLECULE WITH A GRAPH - Modelling a molecule by means of a graph, said graph comprising vertices and edges, each edge having a specific type, and said graph having cyclic orderings on the half-edges about at least one of the vertices, said system comprising means for determining the cyclic orderings on the half-edges about said at least one vertex by means of the spatial coordinates of the constituent atoms of the molecule, and means for determining the type of each edge of the graph by means of the relative spatial location of the constituent atoms of the molecule. Thereby automatic classification, comparison, specification, analysis and/or prediction of molecular structures can be provided because these molecular structures are represented by explicit combinatorial objects, and descriptors can be derived from the graph constructed in this manner. The descriptors are automatically computable from molecular databases, such as PDB or CATH, with no qualitative human intervention or subjective criteria. The invention can be applied to macromolecular structures such as proteins, protein globules, ligands, polymers, nucleotides, nucleic acids, RNA and DNA. | 10-27-2011 |
Niels Knudsen, Humlebaek DK
| Patent application number | Description | Published |
|---|---|---|
| 20080238754 | TIME CONTINUOUS PIPELINE ANALOG-TO-DIGITAL CONVERTER - A Sampled Pipeline Subranging Converter (SPSC) may include at least one stage—e.g. at least the input stage—operating in a time-continuous fashion. In the time continuous input stage, the analog input may be processed in two parallel paths. A lower path may comprise a track-and-hold (T/H) element, an Analog-to-Digital-Converter (ADC) and a Digital-to-Analog-Converter (DAC). The T/H element may be optional and may be present if required by the ADC. The signal entering the lower path may be sampled at the desired conversion rate. The time continuous stage(s) may additionally be configured with an upper path that includes a delay element configured to receive the analog input, a Low-Pass (LP) filter coupled to the delay element, and an anti alias filter. The output generated by the DAC may be subtracted from the output of the LP filter, and the resulting difference signal may be provided to the anti alias filter, which in turn may generate the residue (or error) output. The digital output of the time continuous converter may be calculated by combining the digital outputs of the various sections. | 10-02-2008 |
Niels Ole Knudsen, Humlebaek DK
| Patent application number | Description | Published |
|---|---|---|
| 20120007760 | INPUT CONVERTER FOR A HEARING AID AND SIGNAL CONVERSION METHOD - In order to minimize noise and current consumption in a hearing aid, an input converter comprising a first voltage transformer and an analog-to-digital converter of the delta-sigma type for a hearing aid is devised. The analog-to-digital converter of the input converter has an input stage, an output stage, and a feedback loop, and the input stage comprises an amplifier (Q | 01-12-2012 |
| 20120010522 | INPUT CONVERTER FOR AN EEG MONITORING SYSTEM, SIGNAL CONVERSION METHOD AND MONITORING SYSTEM - In order to minimize noise and current consumption in an EEG monitoring system ( | 01-12-2012 |
Ove Knudsen, Smorum DK
| Patent application number | Description | Published |
|---|---|---|
| 20090169038 | HEARING DEVICE AND METHOD FOR A WIRELESS RECEIVING AND/OR SENDING OF DATA - The present invention is related in particular to means for a wireless communication to and from a hearing device ( | 07-02-2009 |
| 20100171667 | MINIATURE PATCH ANTENNA - The invention relates to a patch antenna for a small size, low-power device adapted for transmitting or receiving electromagnetic radiation in a predefined frequency range. The invention further relates to a method of driving a patch antenna and to the use of a patch antenna. The object of the present invention is to provide a patch antenna suitable for a small size, low power device. The problem is solved in that the antenna comprises at least one patch comprising an electrically conductive material and having an upper and lower face, the at least one patch being supported on its lower face by an intermediate material comprising a material having a negative magnetic permeability and/or a negative electrical permittivity, at least over a part of the predefined frequency range. The present invention provides an alternative scheme for manufacturing a patch antenna for a small size, low power device. The invention may e.g. be used for establishing a wireless interface in a portable communication device. | 07-08-2010 |
| 20100202639 | HEARING AID WITH ANTENNA FOR RECEPTION AND TRANSMISSION OF ELECTROMAGNETIC SIGNALS - The invention regards a communication device which is adapted for placement in a users ear. The communication device comprises a shell part enclosing an input transducer for receiving an input signal, a signal processing device and an output N transducer for providing a signal perceivable as sound, a battery located at a surface part of the shell which is facing away from the head of the user, a transmission and reception circuit for transmission and/or reception of electromagnetic energy. According to the invention an antenna for radiating and/or receiving electromagnetic energy is provided such that it has a first surface turned towards the surroundings and a second surface located in close proximity of the battery. | 08-12-2010 |
Ove Knudsen, Smoerum DK
| Patent application number | Description | Published |
|---|---|---|
| 20090046879 | MULTIPURPOSE ANTENNA UNIT AND A HEARING AID COMPRISING A MULTIPURPOSE ANTENNA UNIT - The invention relates to an antenna unit for wireless communication to a multitude of wireless interfaces comprising a multitude of individual antennas, each antenna comprising a coil comprising at least one winding and the individual antennas embrace the same volume and to a hearing aid comprising such antenna unit. The object of the present invention is to provide an antenna unit and a hearing aid providing several wireless interfaces at a relatively small volume. The problem is solved in that at least one of the coils is adapted for providing an inductive coupling to another device. Among the advantages are reduced space/volume, reduced cost and reduced sensitivity to production tolerances compared to a solution comprising individual, separate antennas. The invention may e.g. be used in wireless communication devices, e.g. mobile telephones, head phones, head sets, hearing aids, etc. | 02-19-2009 |
Philip Skov Knudsen, Hellerup DK
| Patent application number | Description | Published |
|---|---|---|
| 20080221967 | Attribute-Based Ordering System - By letting the needs of customers be specified by the corresponding resource attributes instead of specific resources, more customer needs can be met and the overall costs of assigning resources to customers can be minimized | 09-11-2008 |
Rene Knudsen, Langa DK
| Patent application number | Description | Published |
|---|---|---|
| 20100051513 | METHOD AND SYSTEM FOR PROCESSING OF ITEMS - A method and system for the processing of items that are supplied to a batching apparatus, where the batching apparatus comprises at least one handling means of the robotic type. By means of the batching apparatus a first process is performed, according to which items are selectively batched in consideration of measured, detected and/or estimated data for the individual items and in consideration of at least one predefined criterion. Particular items are identified and led to another process, the particular items being items that are deviant in relation to one or more predefined parameter(s) relating to the batching and/or items that have not been selected to be batched during the first process. | 03-04-2010 |
Sanne Moller Knudsen, Vaerlose DK
| Patent application number | Description | Published |
|---|---|---|
| 20080275066 | Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists - The invention provides compounds of formula (I) for use as GLP-1 receptor agonists. | 11-06-2008 |
| 20090054315 | Counteracting Drug-Induced Obesity Using GLP-1 Agonists - The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug. | 02-26-2009 |
Sanne Møller Knudsen, Vaerlose DK
| Patent application number | Description | Published |
|---|---|---|
| 20110275559 | Long-Acting Y2 and/or Y4 Receptor Agonists - The present invention relates to a PYY or PP peptide derivative or analogue thereof derivatised with one or more serum albumin binding side chains comprising a dis-tal tetrazole or carboxylic acid group. Moreover, the invention relates to compositions hereof and methods of treatment of conditions responsive to Y receptor modulation. | 11-10-2011 |
Soren Knudsen, Malov DK
| Patent application number | Description | Published |
|---|---|---|
| 20090029000 | Barley for Production of Flavor-Stable Beverage - According to the invention, there is provided null-LOX-1 barley and plant products produced thereof, such as malt manufactured by using barley kernels defective in synthesis of the fatty acid-converting enzyme lipoxygenase-1. Said enzyme accounts for the principal activity related to conversion of linoleic acid into 9-hydroperoxy octadecadienoic acid, a lipoxygenase pathway metabolite, which-through further enzymatic or spontaneous reactions may lead to the appearance of trans-2-nonenal. The invention enables brewers to produce a beer devoid of detectable trans-2-nonenal-specific off flavors, even after prolonged storage of the beverage. | 01-29-2009 |
| 20110318469 | Barley with reduced lipoxygenase activity and beverage prepared therefrom - According to the invention, there is provided barley with total loss of functional lipoxygenase (LOX)-1 and LOX-2 enzymes, and plant products produced thereof, such as malt manufactured by using barley kernels defective in the synthesis of the fatty acid-dioxygenating enzymes LOX-1 and LOX-2. Said enzymes account for the principal activities related to dioxygenation of linoleic acid into 9- and 13-hydroperoxy octadecadienoic acid, respectively. 9-Hydroperoxy octadecadienoic acid represents a LOX pathway metabolite, which—through further enzymatic or spontaneous reactions—may lead to the appearance of trans-2-nonenal (T2N). The invention enables brewers to produce a beer having insignificant levels of stale, T2N-specific off-flavors, even after prolonged storage of the beverage. | 12-29-2011 |
Søren Knudsen, Malov DK
| Patent application number | Description | Published |
|---|---|---|
| 20110195151 | BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE - According to the invention, there is provided null-LOX-1 barley and plant products produced thereof, such as malt manufactured by using barley kernels defective in synthesis of the fatty acid-converting enzyme lipoxygenase-1. Said enzyme accounts for the principal activity related to conversion of linoleic acid into 9-hydroperoxy octadecadienoic acid, a lipoxygenase pathway metabolite, which-through further enzymatic or spontaneous reactions-may lead to the appearance of trans-2-nonenal. The invention enables brewers to produce a beer devoid of detectable trans-2-nonenal-specific off flavors, even after prolonged storage of the beverage. | 08-11-2011 |
| 20110293779 | BARLEY AND MALT-DERIVED BEVERAGES WITH LOW DMS LEVEL - According to the invention, there is provided barley-derived beverages characterized by notably reduced levels of both dimethyl sulfide (DMS) and/or its precursor S-methyl-L-methionine (SMM), or lacking said compounds. In addition, the invention relates to methods for producing the above-mentioned beverages—and also to barley plants useful in the preparation of such beverages, as well as other plant products prepared from said plants. Utilization of the invention clears the way for making improved production procedures of beverages with improved taste profiles, and promises also for notable reductions in the thermal energy input for production of beer. | 12-01-2011 |
Steen Knudsen, Birkeroed DK
| Patent application number | Description | Published |
|---|---|---|
| 20110195412 | Predictive Biomarkers for Response to Exercise - A set of biomarkers have been identified that allows one to predict subjects who will respond to an exercise regime in term of cardiorespiratory fitness as assessed by maximal oxygen uptake. These predictions may be used, for example, to predict risk of cardiovascular disease, to design a more effective program for cardiac rehabilitation, to predict capacity for athletic performance or physically demanding occupation, and to predict ability to maintain functional capacity with aging using exercise. | 08-11-2011 |
Steen Knudsen, Birkroed DK
| Patent application number | Description | Published |
|---|---|---|
| 20090023149 | Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy - The present invention features methods, kits, and devices for predicting the sensitivity of a patient to a compound or medical treatment. The invention also features methods for identifying gene biomarkers whose expression correlates to treatment sensitivity or resistance within a patient population or subpopulation. | 01-22-2009 |